The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH
Abstract Non-alcoholic fatty liver disease (NAFLD) has become the first major chronic liver disease in developed countries. 10–20% of NAFLD patients will progress to non-alcoholic steatohepatitis (NASH), and up to 25% of NASH patients may develop cirrhosis within 10 years. Therefore, it is critical...
Saved in:
| Main Authors: | Xuan Shen, Wenxing Zheng, Xinna Du, Yuping Chen, Xianping song, Liucai Yang, Qi Yuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-68207-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH
by: Xuan Shen, et al.
Published: (2025-06-01) -
Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis
by: Dongwei Guan, et al.
Published: (2025-06-01) -
LGR6 modulates intervertebral disc degeneration through regulation of macrophage efferocytosis
by: Fudong Li, et al.
Published: (2025-04-01) -
The potential of efferocytosis for the treatment of bronchial asthma: A review of current trends, mechanisms and prospects
by: Baohe Liu, et al.
Published: (2025-09-01) -
Efferocytosis in tissue engineering: A comprehensive review of emerging therapeutic strategies for enhanced tissue repair and regeneration
by: Yue-Qi Zhang, et al.
Published: (2025-10-01)